arrow
H

Hind Rafei

The University of Texas MD Anderson Cancer Center
H指数:21
被引数:2,177

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ex Vivo Mesenchymal Progenitor Cell-based Cord Blood Cell Expansion and Exofucosylation to Enhance Transplant Engraftment

离体间充质祖细胞介导的脐带血细胞扩增及外岩藻糖基化,以增强移植植入效果

2025-11-190
PRE
Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potency

全基因组CRISPR筛选鉴定出增强CAR-NK细胞抗肿瘤效力的关键靶点

2025-08-210
OAAI
Author Correction: Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial

作者更正: 同种异体NK细胞与双特异性先天细胞衔接器治疗难治性复发性淋巴瘤: 1期试验

2025-06-260
PRE
CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells

Rafei, H.; Basar, R.; Acharya, S.; Hsu, Y.-S.; Liu, P.; Zhang, D.; Bohn, T.; Liang, Q.; Mohanty, V.; Upadhyay, R.; 等. CREM是NK细胞中CAR和IL-15信号通路的调控检查点。Nature 2025, 643, 1076–1086. [Google Scholar] [CrossRef] [PubMed]

Nature
IF48.5
2025-06-040
OAAI
Overcoming CD226-related immune evasion in acute myeloid leukemia with CD38 CAR-engineered NK cells

通过CD38 CAR工程化NK细胞克服急性髓系白血病中CD226相关的免疫逃逸

2025-01-010
OA
BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML
2024-09-110
PRE
CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis
2024-07-223
PRE
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial
2024-02-232
PRE
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial

CD19 b细胞肿瘤中同种异体CD19-specific car-nk细胞的安全性,有效性和反应决定因素: 1/2期试验

2024-01-1889
OAAI
KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape (vol 28, pg 2133, 2022)
2024-01-050
OA
Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering
2023-07-2838
OAAI
KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape
2022-09-2983
OA
Engineered cord blood megakaryocytes evade killing by allogeneic T-cells for refractory thrombocytopenia
2022-09-201
OAAI